Mitsubishi Tanabe recalls drugs

Mitsubishi Tanabe recalls drugs

TOKYO, Japan - Mitsubishi Tanabe Pharma Corp. President Michihiro Tsuchiya (front) bows in apology during a press conference in Tokyo on Jan. 26, 2011. The drugmaker initiated a voluntary recall of three injection solution products that one of its subsidiaries may have shipped without conducting quality tests. (Kyodo)

  • Product Code
  • ILEA000331525
  • Registered date
  • 2011/1/26 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • Media size
  • 1377 × 1303 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 1.04(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Toyota's improper vehicle testing

    Toyota's improper vehicle testing

    Toyota Motor Corp. Chairman Akio Toyoda bows in apology during a press conference in Tokyo on June 3, 2024, after the company improperly obtained vehicle certifications for seven models of car by conducting safety tests in ways not specified by the government.
      CORRECTED: Mazda Motor's improper vehicle testing

      CORRECTED: Mazda Motor's improper vehicle testing

      Mazda Motor Corp. President Masahiro Moro bows in apology after the company improperly obtained vehicle certifications for five car models by conducting safety tests in ways not specified by the government during a press conference in Tokyo on June 3, 2024.
        Daihatsu Motor President Okudaira

        Daihatsu Motor President Okudaira

        Daihatsu Motor Co. President Soichiro Okudaira (C) bows at a press conference in Tokyo on Dec. 20, 2023, as he apologizes over his company's improper vehicle tests. The Toyota Motor Corp. subsidiary announced the same day it will stop all shipments in domestic and overseas markets as most of its car models are affected.
          Sharp admits sales padded at subsidiary

          Sharp admits sales padded at subsidiary

          Sharp Corp. President Katsuaki Nomura bows in apology at a press conference in Sakai, Osaka, on March 12, 2021. He said Kantatsu Co., one of its subsidiaries, had padded its sales by around 7.5 billion yen ($69 million) through fraudulent accounting.
            Mizuho Bank ATM glitch

            Mizuho Bank ATM glitch

            Mizuho Bank President and CEO Koji Fujiwara (R) bows in apology at a press conference in Tokyo on March 1, 2021, over a system failure that prevented customers from withdrawing cash from thousands of the major Japanese bank's machines.
              Press conference on the identification of existing drugs in Japan

              Press conference on the identification of existing drugs in Japan

              The photo shows Professor Junichiro Inoue of the Institute of Medical Science, University of Tokyo taking off his mask for explanation. (March 18, 2020, Yasuda Auditorium, University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
                Press conference on the identification of existing drugs in Japan

                Press conference on the identification of existing drugs in Japan

                Photo shows Yuji Yamanashi, Director of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
                  Press conference on the identification of existing drugs in Japan

                  Press conference on the identification of existing drugs in Japan

                  Photo shows Professor Junichiro Inoue of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
                    Press conference on the identification of existing drugs in Japan

                    Press conference on the identification of existing drugs in Japan

                    Photo shows Professor Junichiro Inoue of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
                      Press conference on the identification of existing drugs in Japan

                      Press conference on the identification of existing drugs in Japan

                      Photo shows Yuji Yamanashi, Director of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)